Beverly M K Biller (B M K Biller)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Community Dwelling

Polycystic Ovary Syndrome

Top Venues

Journal of the Endocrine Society

Journal of endocrinological investigation

Expert review of endocrinology & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Rosario Pivonello, Maria Fleseriu, John D Newell-Price, Akira Shimatsu, R A Feelders, Pinar Kadioglu, A Tabarin, Thierry Brue, Eliza B Geer, A Piacentini, A M Pedroncelli, Beverly M K Biller
Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease. Journal of endocrinological investigation (2024)
Beverly M K Biller, Charlotte Höybye, Jean-Marc Ferran, Nicky Kelepouris, Navid Nedjatian, Anne Helene Olsen, Matthias M Weber, Murray B Gordon
Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER. Journal of the Endocrine Society 7 (6) (2023)
Beverly M K Biller, Charlotte Höybye, Jean-Marc Ferran, Nicky Kelepouris, Navid Nedjatian, Anne Helene Olsen, Matthias M Weber, Murray B Gordon
Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER. Journal of the Endocrine Society 7 (6) (2023)
Yutaka Takahashi, Beverly M K Biller, Hidenori Fukuoka, Ken K Y Ho, Michael Højby Rasmussen, Navid Nedjatian, Claus Sværke, Kevin C J Yuen, Gudmundur Johannsson
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency. Pituitary (2022)
Maria Fleseriu, Beverly M K Biller
Treatment of Cushing's syndrome with osilodrostat: practical applications of recent studies with case examples. Pituitary 25 (6) (2022)
Beverly M K Biller, Charlotte Höybye, Paul V Carroll, Murray B Gordon, Anna Camilla Birkegård, Nicky Kelepouris, Navid Nedjatian, Matthias M Weber
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program. Pituitary 24 (4) (2021)
Maria Fleseriu, Richard J Auchus, Rosario Pivonello, Roberto Salvatori, Sabina Zacharieva, Beverly M K Biller
Levoketoconazole: a novel treatment for endogenous Cushing's syndrome. Expert review of endocrinology & metabolism 16 (4) (2021)